ADRB2 and Parkinson disease: Using a hα-SYN mouse model of PD, we showed that DSP-4 pretreatment protects dopaminergic neuron degeneration, likely due to an increase in extracellular NE and signaling in the brain, since using propranolol a β-AR blocker prevented DSP-4-mediated neuroprotection.